How should shivering on postoperative days 3–4 be managed in a patient after coronary artery bypass grafting (CABG)?

Management of Post-CABG Shivering on Days 3-4

For shivering occurring on postoperative days 3-4 after CABG, use meperidine (12.5-50 mg IV) as first-line pharmacologic treatment, as it has the most potent anti-shivering properties among opioids. 1

Initial Assessment

At postoperative days 3-4, shivering this late after surgery requires evaluation for:

• Core temperature: Check for hypothermia (though less likely this far post-op) or fever suggesting infection
• Infection: Surgical site infection, pneumonia, or other sources—common CABG complications that can trigger shivering 2
• Pain: Inadequate analgesia can provoke shivering independent of temperature 3

Stepwise Treatment Algorithm

First-Line Non-Pharmacologic Measures

• Skin counterwarming: Apply warming to extremities (ears, palms, soles) to reduce shivering threshold by ~4°C per degree of skin warming 4
• Environmental warming: Increase room temperature, use warming blankets
• Warm IV fluids if administering fluids 5

Second-Line Pharmacologic Treatment

If non-pharmacologic measures fail:

1. Meperidine 12.5-50 mg IV (preferred agent)

   • Most effective opioid for shivering suppression
   • Lowers shivering threshold and directly suppresses tremor 4, 1, 4
   • Caution: Active metabolite can cause neurotoxicity; decreases seizure threshold 4

2. Alternative opioids if meperidine contraindicated:

   • Fentanyl bolus + infusion (0.5-15 μg/kg/h) 4
   • Less effective than meperidine but safer profile

3. Adjunctive agents (use in combination):

   • Acetaminophen: Non-sedating, reduces cytokine-mediated shivering 6, 7
   • Magnesium sulfate 2-4 g IV: Modest effect but safe adjunct 4

Third-Line Options for Refractory Shivering

Only if above measures fail:

• Dexmedetomidine infusion (0.2-0.7 μg/kg/h): Effective anti-shivering with less respiratory depression 4, 3, 6
• Propofol (20-60 μg/kg/min): If sedation acceptable 4, 6

Avoid Neuromuscular Blockade

Do not use neuromuscular blocking agents at this stage post-CABG 6:

• Risk of ICU-acquired weakness
• Masks neurologic examination
• Can hide seizures
• Only justified during active targeted temperature management (not applicable on POD 3-4)

Critical Pitfalls

• Rule out infection first: Fever-induced shivering on POD 3-4 suggests surgical site infection, pneumonia, or other complications requiring antibiotics, not just symptomatic treatment 4, 2
• Assess pain adequately: Uncontrolled pain can trigger shivering reflexes; optimize analgesia before adding anti-shivering agents 3
• Avoid benzodiazepines: Highly deliriogenic with prolonged effects; not indicated for shivering 4
• Monitor for meperidine toxicity: Limit duration of use; watch for tremors, myoclonus, or seizures from metabolite accumulation 4

Evidence Quality Note

The strongest guideline evidence comes from cardiac arrest/TTM protocols 4, 6, with meperidine specifically recommended for postoperative shivering by ASA guidelines 1. While these guidelines address different clinical contexts, the pharmacologic principles for shivering management are directly applicable to post-CABG patients, with the caveat that infection must be ruled out given the timing (POD 3-4 is peak risk for postoperative complications) 2.